Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival. | Clin Med Res;7(1-2): 4-13, 2009 Jun. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival.

Onitilo, Adedayo A; Engel, Jessica M; Greenlee, Robert T; Mukesh, Bickol N.

Affiliation

Onitilo AA; Department of Hematology/Oncology, Marshfield Clinic Weston Center, Weston, Wisconsin 54401, USA. onitilo.adedayo@marshfieldclinic.org

Clin Med Res ; 7(1-2): 4-13, 2009 Jun.

Article in En | MEDLINE | ID: mdl-19574486

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptors, Progesterone / Receptors, Estrogen / Receptor, ErbB-2 Type of study: Observational_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Clin Med Res Year: 2009 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptors, Progesterone / Receptors, Estrogen / Receptor, ErbB-2 Type of study: Observational_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Clin Med Res Year: 2009 Document type: Article Affiliation country: